Free Trial

Shuttle Pharmaceuticals (SHPH) SEC Filings & 10K Form

Shuttle Pharmaceuticals logo
$0.62 +0.02 (+3.70%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.61 -0.01 (-1.13%)
As of 02/21/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Shuttle Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/13/2025
5:22 AM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/06/2025
6:33 PM
Richards Steven M (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5/A
02/06/2025
6:34 PM
Schafer Joshua (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5/A
02/05/2025
3:55 PM
Brown Milton (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2025
6:30 PM
Richards Steven M (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2025
6:30 PM
Schafer Joshua (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/24/2025
8:39 AM
Shuttle Pharmaceuticals (Filer)
Form 424B3
01/23/2025
11:15 PM
Shuttle Pharmaceuticals (Filer)
Form EFFECT
01/21/2025
7:40 PM
Shuttle Pharmaceuticals (Filer)
Form RW
01/21/2025
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
5:37 AM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/07/2025
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:16 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:01 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
7:57 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
11:05 AM
Shuttle Pharmaceuticals (Filer)
Form 424B4
10/29/2024
11:15 PM
Shuttle Pharmaceuticals (Filer)
Form EFFECT
10/29/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:05 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:49 AM
Shuttle Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
10/25/2024
7:52 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
8:06 AM
Shuttle Pharmaceuticals (Filer)
Form S-1/A
10/17/2024
4:17 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:00 PM
Jung Mira (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
5:04 AM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/13/2024
7:25 PM
Shuttle Pharmaceuticals (Filer)
Form 424B3
09/13/2024
4:00 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
4:23 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
3:26 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
8:51 PM
Shuttle Pharmaceuticals (Filer)
Form 10-K/A
09/03/2024
8:52 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q/A
09/03/2024
8:54 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/28/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
5:08 AM
Shuttle Pharmaceuticals (Filer)
Form NT 10-Q
08/07/2024
7:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
8:45 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
3:59 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:42 PM
Lorber Timothy J. (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

06/18/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
5:12 AM
Shuttle Pharmaceuticals (Filer)
Form PRE 14A
05/22/2024
3:15 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
4:01 PM
Shuttle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
9:05 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:36 PM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
4:06 PM
Shuttle Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/22/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
5:07 AM
Shuttle Pharmaceuticals (Filer)
Form 424B3
03/21/2024
4:28 PM
Shuttle Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2024
4:02 PM
Senanayake Chris (Reporting)
Shuttle Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:18 PM
Shuttle Pharmaceuticals (Issuer)
Vander Hoek Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:00 AM
Shuttle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners